Periodic Reporting for period 1 - ENZYME-DCC (Enzyme-Mediated Dynamic Combinatorial Chemistry)
Période du rapport: 2022-07-01 au 2024-12-31
The specific aims are:
1. To achieve templated enzymatic selective synthesis of large-ring cyclodextrins (cyclodextrins (CDs) with more than 8 glucose units).
2. To explore cyclodextrin glucanotransferase-mediated dynamic mixtures of modified CDs, and, using thiol-functionalised CDs, develop a doubly dynamic system that combines reversible transglycosylation with disulfide exchange.
3. To generate phosphorylase-mediated dynamic mixtures of linear α-1,4-glycans and employ templates to achieve length- and sequence-selective synthesis.
4. To establish a fuelled far-from-equilibrium system for continuous large-ring CD synthesis using templates together with a series of interconnected dynamic enzymatic transformations.
The ultimate success of ENZYME-DCC will be to bring about a paradigm shift in the way that enzymes are employed in biocatalysis, such that reversible reactions, thermodynamic control, and templates come into play. By embracing the complexity of the dynamic mixtures generated, new products, reactivities and recognition motifs will be discovered. In contrast to nucleic acids and proteins, biosynthetic pathways to complex oligosaccharides are not guided by templates. In this research programme, novel methodology will be developed that uses designed, artificial templates to control enzymatic glycosylation, thus capturing the enhanced value of supramolecular chemistry and enzymology working together.
Large-ring cyclodextrins have been very little explored in the past, due to synthetic inaccessibility. Previously, only a few hundred milligrams of δ-CD, formed from 9 glucose units, had ever been synthesised or isolated. We have developed a scalable method for the production of δ-CD that gives high yield, high purity, easy isolation of the product and uses a cheap starting material. It is our hope that by making this larger cyclodextrin accessible, it will find many applications, and one day, δ-CD will be as ubiquitous as the well-known α-, β-, and γ-cyclodextrins.